Shandong Keyuan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 146.28 million compared to CNY 124.23 million a year ago. Revenue was CNY 146.28 million compared to CNY 124.23 million a year ago.

Net income was CNY 21.53 million compared to CNY 32.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.1988 compared to CNY 0.3952 a year ago. Diluted earnings per share from continuing operations was CNY 0.1988 compared to CNY 0.3952 a year ago.